4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-036756
Chief Commercial Officer sold 10,257 shares at $0.73 ($7,488)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baldry Mark Chief Commercial Officer | 2023-11-01 | Sale 10b5-1 | −10,257 | $0.73 | $7,488 | 24,690 | D |
| Open-market sales · 10,257 sh · avg $0.73 · $7,488 | |||||||
Loading xslF345X05/wk-form4_1699043973.xml…